These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17999298)

  • 1. Cervical cancer in women aged less than 25: East Kent experience.
    Nair MS; Bhandari HM; Nordin AJ
    J Obstet Gynaecol; 2007 Oct; 27(7):706-8. PubMed ID: 17999298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anglian Genitourinary Medicine Audit Group -- cervical cytology screening in HIV-positive women.
    Harry TC
    Int J STD AIDS; 2009 Jan; 20(1):58-60. PubMed ID: 19103897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
    Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
    Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
    Herbert A; Johnson J; Patnick J
    Cytopathology; 1995 Oct; 6(5):301-3. PubMed ID: 8785367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications.
    Coleman DV; Poznansky JJ
    Cytopathology; 2006 Jun; 17(3):127-36. PubMed ID: 16719855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer incidence and screening: status report on women in the United States.
    Martin LM; Parker SL; Wingo PA; Heath CW
    Cancer Pract; 1996; 4(3):130-4. PubMed ID: 8826141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of cervical screening in women under 25 years (2005-2009).
    Ali AA; Richardson D; Hill N
    Arch Gynecol Obstet; 2013 Apr; 287(4):765-9. PubMed ID: 23183714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational care or rationing care? The case of cervical screening across the United Kingdom.
    Flynn H; Lewis P
    Health Policy; 2013 Oct; 112(3):197-201. PubMed ID: 23910733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
    Lynge E; Poll P
    IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening history of women with invasive cervical cancer in north-east Italy.
    Zucchetto A; Franceschi S; Clagnan E; Serraino D; Zanier L; Franzo A;
    Eur J Obstet Gynecol Reprod Biol; 2010 Oct; 152(2):200-4. PubMed ID: 20667643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The agreement between self-reported cervical smear abnormalities and screening programme records.
    Canfell K; Beral V; Green J; Cameron R; Baker K; Brown A
    J Med Screen; 2006; 13(2):72-5. PubMed ID: 16792828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire.
    Paterson ME; Peel KR; Joslin CA
    Br Med J (Clin Res Ed); 1984 Oct; 289(6449):896-8. PubMed ID: 6434133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papanicolaou smear screening and cervical cancer. What can you expect?
    Stenkvist B; Bergström R; Eklund G; Fox CH
    JAMA; 1984 Sep; 252(11):1423-6. PubMed ID: 6471269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.